About the Medicinal Chemistry and Drug Discovery Group
To discuss new developments in the area of medicinal chemistry and drug discovery.
Have something to say?
Join LinkedIn for free to participate in the conversation. When you join, you can comment and post your own discussions.
Join LinkedIn-
Medicinal chemistry/drug discovery commercialization: Is it pressure or requirement? Can we discuss FDA point of view and economic point...
In today's world, medicinal chemist is pressurized more in terms of sustaining the job but it can be reality from the company side as...
-
Is there a alternative to a FLIPR Tetra system for GPCR assay ? (We do not have facilities to support radio-labelled ligands, and FLIPR...
Our group would like to perform GPCR assays by ourselves, rather then sending them to our collaborator, who takes a lot of time and only...
Most Popular Discussions
Surendra
Atefeh
Lourdes
Danielle
Medical Director (Director of Clinical Dev) linkedin.com
Sterling Life Sciences - San Francisco Bay Area
Evris
A computational screen identifies a small-molecule activator of proapoptotic BAX that selectively binds to the BAX trigger site, inducing characteristic conformational changes, oligomerization and BAX-dependent cell death.
Margaret
Poonam
Nirav
Is there a alternative to a FLIPR Tetra system for GPCR assay ? (We do not have facilities to support radio-labelled ligands, and FLIPR...
Our group would like to perform GPCR assays by ourselves, rather then sending them to our collaborator, who takes a lot of time and only ...
Dr. Mandar
vibha
Nasimul
